CKD Diagnosis and Staging

Diagnosis and Staging is the first of 20 half-hour CME/CEU modules written for and by Advanced Practitioners. The goal is to orient the new nephrology Advanced Practitioner but it can also be a great review for the experienced AP.

In this activity the authors review the 2012 KDIGO staging guidelines. While many may feel they know the stages of CKD, the authors throw in a couple of unexpected queries to challenge AP’s pre-existing notions. Interactive case studies will be presented to the learners throughout. 

Target Audience

  • Advanced Practitioners 

Learning Objectives

Upon completion of this activity you will be better able to:

  • Define CKD stages using the 2012 KDIGO guidelines
  • Discuss urine creatinine to albumin ratios (UACR) in relationship to progression of CKD
  • Highlight health disparities in CKD staging
Course summary
Available credit: 
  • 0.50 ANCC Nurse Contact Hours
  • 0.50 Attendance
  • 0.50 Category I Credit for Physician Assistants
Course opens: 
01/31/2018
Course expires: 
01/31/2020
Cost:
$25.00
Parent activity set: 
Rating: 
0

Jane S. Davis, CRNP, DNP
Nurse Practitioner
University of Alabama at Birmingham
Birmingham, AL
Disclosure: Received honoraria and/or support from: Amgen.

Kim Zuber, PA-C, MS
Executive Director
American Academy of Nephrology PAs
Oceanside, CA
Disclosure: Received honoraria and/or support from: Amgen and Janssen. 

Planning Committee Disclosures

Susan Brown, ARNP 
Great River Health Systems
West Burlington, IA
Disclosure: Has no financial relationships with commercial interest(s).

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

 
 
DECLARATION OF DISCLOSURE:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

UNLABELED/INVESTIGATIONAL USE:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

ACCREDITATION/DESIGNATION OF CREDIT STATEMENTS:

The National Kidney Foundation is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

 

Nurse Practitioner 

Awarded .5 contact hours of continuing nursing education.

Physician Assistant 

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AAPA accepts Category I credit from AOACCME, prescribed credit from AAFP, and AMA Category I Credit(s)TM from organizations accredited by ACCME. Physician assistants may receive a maximum of 0.5 hours of Category I credit for completing this program.

Available Credit

  • 0.50 ANCC Nurse Contact Hours
  • 0.50 Attendance
  • 0.50 Category I Credit for Physician Assistants

Accreditation Period

Course opens: 
01/31/2018
Course expires: 
01/31/2020

Price

Cost:
$25.00
Please login or register for a PERC account to take this course.
DISCLAIMER:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.